Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
- 作者Ross L. Levine; Martha Wadleigh; Jan Cools; Benjamin L. Ebert; Gerlinde Wernig; Brian J.P. Huntly; Titus J. Boggon; Iwona Wlodarska; Jennifer J. Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C. Lee; Stacey Gabriel; Thomas Mercher; Alan D’Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A. Mesa; Ayalew Tefferi; James D. Griffin; Michael J. Eck; William R. Sellers; Matthew Meyerson; Todd R. Golub; Stephanie J. Lee; D. Gary Gilliland
- 卷第7卷
- 期第4期
- 印刷ISSN1535-6108
- 文件大小459.18KB
- 发表时间2005
- DOI10.1016/j.ccr.2005.03.023
- 页码387-397
Focus on multiple myeloma at ASH 2015Zojer, Niklas · memo - Magazine of European Medical Oncology · 2016
Therapeutic Options in Multiple Myeloma: Focus on BortezomibRoodman, G. David · Clinical Medicine. Therapeutics · 2009
<p>Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma</p>Parrondo, Ricardo D; Sher, Taimur · OncoTargets and Therapy · 2019
Management of Multiple Myeloma and Myelodysplastic Syndrome: Focus on LenalidomideVolk, Christine; Klein, Ulrike · Clinical Medicine. Therapeutics · 2009
The Multiple Myeloma Research Foundation's evolving focus on drug R&DGiusti, Kathy · Nature Biotechnology · 2012
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibLonial, Sagar · Biologics: Targets and Therapy · 2013
Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myelomaFriend, Reed; Bhutani, Manisha; Voorhees, Peter; Usmani, Saad · Drug Design, Development and Therapy · 2017
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M. Negri; Douglas W. McMillin; Jake Delmore; Nicholas Mitsiades; Patrick Hayden; Steffen Klippel; Teru Hideshima; Dharminder Chauhan; Nikhil C. Munshi; Carolyn A. Buser; John Pollard; Paul G. Richardson; Kenneth C. Anderson; Constantine S. Mitsiades · 2009
Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironmentConstantine S. Mitsiades; Nicholas S. Mitsiades; Paul G. Richardson; Nikhil C. Munshi; Kenneth C. Anderson · 2007
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactionsConstantine S. Mitsiades; Nicholas S. Mitsiades; Nikhil C. Munshi; Paul G. Richardson; Kenneth C. Anderson · 2006